Clin2
NCT06610565Possibly a fitRecruiting

Fasting-mimicking diet for breast cancer side effects

Breast Cancer

Part of Cancer, Skin clinical trials.

This study tests if a special diet that mimics fasting can help reduce side effects from hormone therapy (aromatase inhibitors) in women with breast cancer. The diet is a low-calorie meal plan designed to lower cholesterol and improve well-being.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have early-stage breast cancer that is estrogen receptor positive
  • You are taking a hormone therapy drug called an aromatase inhibitor for at least 6 months
  • Your total cholesterol is above 200 mg/dL
  • You do not have diabetes or a history of eating disorders
  • You are able to follow the diet and provide dietary information over the phone

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05968677Recruiting
Amino acids and flavonoids to reduce chemotherapy side effects

This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.

Pavia
NCT07077018Not yet recruiting
Fasting-mimicking diet during chemo for hormone-positive breast cancer

This trial tests whether a special low-calorie diet that mimics fasting can make chemotherapy more effective for people with hormone-receptor-positive breast cancer. If you qualify, you would follow this diet for a few days before and during your chemo cycles.

Guangzhou
NCT07378306Recruiting· Phase 2
Fasting-mimicking diet with chemo-immunotherapy for triple-negative breast cancer

This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.

Guangzhou, Guangdong
NCT06106477Recruiting
Intermittent fasting for women with early breast cancer

This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.

Milwaukee, Wisconsin
NCT06214598Recruiting
Anti-inflammatory diet for breast cancer patients on hormone therapy

This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.

Belgrade
NCT04469296Recruiting
Diet changes before surgery for hormone-receptor breast cancer

This trial tests whether changing your diet before your breast surgery can help people with early, hormone-receptor (ER/PR+) breast cancer. It focuses on patients who have not started treatment yet and want to keep surgery as the main treatment.

Montpellier, Herault

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.